Lilly’s Taltz label updated to include data on psoriasis in genital area

Eli Lilly's and Co.'s Taltz, or ixekizumab, is the first medication for moderate to severe plaque psoriasis to receive FDA ap -More- …
Read the full story: BIO SmartBrief